Straumann Holding AG (STMN.SW) stock: key figures, P/E, revenue and dividend
Health Care · Switzerland · ISIN CH1175448666
Straumann Holding AG financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 2.50 bn CHF | 2.61 bn CHF |
| Gross profit | 1.78 bn CHF | 1.79 bn CHF |
| Operating income | 649.65 m CHF | 653.93 m CHF |
| EBIT | 601.00 m CHF | 537.00 m CHF |
| Net income | 388.00 m CHF | 355.00 m CHF |
| Diluted EPS – continuing operations | 2.43 CHF | 2.25 CHF |
Full history since 1996, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Straumann Holding AG
Straumann Holding AG provides tooth replacement and orthodontic solutions in Switzerland, the United States, China, Germany, Brazil, Japan, France, and internationally. It operates through Sales Europe, Middle East and Africa; Sales North America; Sales Asia Pacific; Sales Latin America; and Operations segments. The company offers dental implants, instruments, CADCAM prosthetics, orthodontic and clear aligners, biomaterials, and digital equipment and solutions for use in tooth correction, replacement, and restoration, as well as to prevent tooth loss. It also provides implant systems, components, and related instruments, as well as healing components, materials and surfaces, surgical sets and instruments, and guided surgery and navigation products; prosthetics, including angled solutions, connections, components, and molar solutions; intra-oral and lab scanners, milling machines, dynamic navigation systems, and 3D printers; consumables, such as blocks, discs, resins, titanium bases, and abutment blanks, as well as scan bodies, analogs, and sleeves; online education; and dentists and dental labs solutions. In addition, the company offers regenerative solutions for tooth preservation, implant-site management, and implant preservation; scanner hardware, software licenses, sterile-packaged products, customer training, and other products; and logistics and supply chain services. Further, it provides thermoplastics; implant treatment referral; high-tech materials; artificial intelligence solutions for dental applications; and 3D orthodontic treatment animations. The company sells its products under the Straumann, Neodent, Medentika, Anthogyr, ClearCorrect, NUVO, and other brands through a network of distribution subsidiaries and partners, and third-party distributors, as well as through its e-shop. It serves clinicals needs, patient segments, and healthcare systems. Straumann Holding AG was founded in 1954 and is headquartered in Basel, Switzerland.
More stocks
- Toast, Inc. (TOST)
- CF Industries (CF)
- Joint Stock Company Kaspi.kz (KSPI)
- Knorr Bremse (KBX.DE)
- Xpeng Inc (XPEV)
- Carlsberg A/S (CARL B.CO)
- ITT INC. (ITT)
- LS Electric (010120.KS)
- Swire Properties Ltd (1972.HK)
- Zebra Technologies (ZBRA)
- Grupo Carso S.A.B. de C.V (GCARSOA1.MX)
- Lundin Mining Corp (LUN.TO)
Not investment advice. All data without warranty, price as of 14.10.2026. Details in the risk notice.